Leading global supplier of apheresis products & customized #primary#cells from peripheral blood, bone marrow, & cord blood for #research and #celltherapy
Listen in - Donors: The Unsung Heroes Advancing Science Podcast - featuring HemaCare discussing the challenges of recruiting donors during the pandemic & the increasingly important role of donation in today’s pharmaceutical landscape: https://t.co/yoxLHeUNGk
#blooddonor#donate
Join Us! GEN Webinar: Addressing the Challenges of Scaling Cell Therapies – Nov. 18th, 2021. Dr. Matthew Hewitt & Dr. Kimberly Negrin will explore these distinct challenges & strategies to mitigate them. Register Today: https://t.co/JPmdI2TAys
#hemacare#advancingdiscoveries
HemaCare materials support a new COVID-19 vaccine clinical trial. Scientists are conducting a Phase I clinical trial for their new dual-antigen vaccine to fight COVID-19. Learn more: https://t.co/wejcXgk7IU
#hemacare#advancingdiscoveries#covid19#vaccine#vaccination#covid
HemaCare’s T-cells are aiding in cancer immunotherapy research for the Cell and Gene Therapy Catapult in the UK. Learn more about this study and how HemaCare’s CD3+ T-cells were used: https://t.co/zqp2kQffmQ
#hemacare#advancingdiscoveries#celltherapy#cancerresearch#tcells
An independent publication cites the use of HemaCare-sourced #PBMCs as starting material for an assay designed to screen for factors that enhance anti-tumor cytotoxic #Tcell activity.
Read more about it>> https://t.co/bn3TbBUed5
#hemacare#advancingdiscoveries#immunotherapy
In Germany, a vaccine designed to target brain tumors has passed Phase I human trials & will move on to Phase II. Learn more about how this vaccine impacts the immune system of patients with brain cancer: https://t.co/vi7G1QZ7Cz
#hemacare#immunotherapy#tcells#cancerresearch
Researchers are seeing positive results when fighting systemic fungal infections by using CAR-T cell therapy. Learn how this immunotherapy, typically used in cancer treatments, has been adapted to battle Cryptococcus infections: https://t.co/FHYtN0ncMe
#hemacare#immunotherapy
Researchers have discovered CAR-T cell therapy can help attack migrant cells in the immune system. Read about it here >>https://t.co/oIzKelRluh
#hemacare#advancingdiscoveries#cart#tcells
Our COVID-19 vaccinated samples (time series) supports your COVID-19 research. Each set includes one pre-vaccination sample, one sample collected 10-30 days after first vaccine administration, one sample 10-30 days after second vaccine administration >>https://t.co/XNfeM5Itvp
Are you investigating the COVID-19 immune response? We support your research efforts by offering a comprehensive portfolio of COVID-19 related products.
SHOP NOW >>https://t.co/N4oSdTL0yW
University of Arizona researchers created a new five-module chimeric antigen receptor T cell that has shown potential to fight against Type 1 diabetes. Read about it here >> https://t.co/aRmoJNXbOo
#hemacare#advancingdiscoveries#tcells#cart
The 6th Annual CAR-TCR Summit is 3 days away. We can’t wait to hear from Dr. @WassimBasheer who will present Wednesday, Sept. 1 at 12:00 EDT.
Visit our virtual booth: https://t.co/iW8k4WRZKS
Register for the event: https://t.co/MTm1f40Ult
#hemacare#advancingdiscoveries
We’re here to help you unravel the immune response mysteries behind the deadly pathology of the virus causing the COVID-19 pandemic. Check out our all-new portfolio of #COVID19 related products here>> https://t.co/OWaLQQEXp5
#hemacare#advancingdiscoveries#newproductlaunch
In part 2 of our special two-part blog series, we explain how receiving the #mRNA#COVID-19 vaccine triggers the human immune system to produce antibodies and facilitates long-term protection>>https://t.co/RuKi7xf1iD
#hemacare#advancingdiscoveries#pbmcs#plasma#serum#tcells